These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6388927)

  • 1. Immunodeficient CBA/N mice respond effectively to Candida albicans.
    Carrow EW; Hector RF; Domer JE
    Clin Immunol Immunopathol; 1984 Dec; 33(3):371-80. PubMed ID: 6388927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein.
    Carrow EW; Domer JE
    Infect Immun; 1985 Jul; 49(1):172-81. PubMed ID: 4008047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge.
    Moser SA; Domer JE; Mather FJ
    Infect Immun; 1980 Jan; 27(1):140-9. PubMed ID: 6987165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intragastric colonization of infant mice with Candida albicans induces systemic immunity demonstrable upon challenge as adults.
    Domer JE
    J Infect Dis; 1988 May; 157(5):950-8. PubMed ID: 3283263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclophosphamide on murine candidiasis.
    Moser SA; Domer JE
    Infect Immun; 1980 Feb; 27(2):376-86. PubMed ID: 6991413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon.
    Garner RE; Kuruganti U; Czarniecki CW; Chiu HH; Domer JE
    Infect Immun; 1989 Jun; 57(6):1800-8. PubMed ID: 2498208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to Candida albicans in genetically distinct mice.
    Hector RF; Domer JE; Carrow EW
    Infect Immun; 1982 Dec; 38(3):1020-8. PubMed ID: 6759403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced immune responses in mice treated with penicillin-tetracycline or trimethoprim-sulfamethoxazole when colonized intragastrically with Candida albicans.
    Domer JE; Hector RF
    Antimicrob Agents Chemother; 1987 May; 31(5):691-7. PubMed ID: 3300536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1993 May; 61(5):1990-5. PubMed ID: 8097493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonspecific and Candida-specific immune responses in mice suppressed by chronic administration of anti-mu.
    Kuruganti U; Henderson LA; Garner RE; Asofsky R; Baker PJ; Domer JE
    J Leukoc Biol; 1988 Nov; 44(5):422-33. PubMed ID: 3141542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1994 Mar; 62(3):1032-8. PubMed ID: 8112837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine candidiasis: cell-mediated immune responses correlate directly with susceptibility and resistance to infection.
    Ashman RB
    Immunol Cell Biol; 1990 Feb; 68 ( Pt 1)():15-20. PubMed ID: 2180815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine defense mechanism against Candida albicans infection. I. Collaboration of cell-mediated and humoral immunities in protection against systemic C. albicans infection.
    Kagaya K; Shinoda T; Fukazawa Y
    Microbiol Immunol; 1981; 25(7):647-54. PubMed ID: 7024741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow colony-formation in vitro after infection of genetically defined inbred mice with Candida albicans.
    Wanasaengsakul S; Ashman RB
    Microb Pathog; 2004 Apr; 36(4):211-7. PubMed ID: 15001227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and humoral immune responses to Candida albicans in subcutaneously infected mice.
    Ponton J; Quindos G; Regulez P; Cisterna R
    Mycopathologia; 1985 Oct; 92(1):11-8. PubMed ID: 3906402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of in vivo administration of recombinant murine gamma interferon on in vitro lymphoproliferative responses following immunization with Candida albicans.
    Garner RE; Kuruganti U; al-Hussaini LA; Czarniecki CW; Domer JE
    Infect Immun; 1992 May; 60(5):1927-35. PubMed ID: 1563784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A.
    Domer JE; Human LG; Andersen GB; Rudbach JA; Asherson GL
    Infect Immun; 1993 May; 61(5):2122-30. PubMed ID: 8478102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of experimental candidiasis in T-cell-deficient mice.
    Sinha BK; Prasad S; Monga DP
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):203-9. PubMed ID: 3314257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis.
    Garner RE; Domer JE
    Infect Immun; 1994 Feb; 62(2):738-41. PubMed ID: 7507901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired immunity to systemic candidiasis in immunodeficient mice: role of antibody to heat-shock protein 90.
    Matthews R; Burnie J
    J Infect Dis; 1992 Nov; 166(5):1193-5. PubMed ID: 1402035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.